Greater Cannabis Company (GCAN) Common Equity (2016 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Common Equity of -$775025.0 in Q1 2026, down 4.5% quarter-over-quarter from -$741649.0 in Q4 2025, and up 5.94% on a YoY basis from -$731557.7 in Q1 2025.
Greater Cannabis Company (GCAN) Common Equity (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Common Equity history runs 11 years deep, the most recent figure standing at -$775025.0 for Q1 2026.
- In Q1 2026, Common Equity rose 5.94% year-over-year to -$775025.0; the TTM figure through Mar 2026 stood at -$775025.0 (up 5.94% YoY), while the FY2025 annual figure was -$741649.0, up 11.74% from the prior year.
- Common Equity was -$775025.0 for Q1 2026 at Greater Cannabis Company, down from -$741649.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of -$544830.0 in Q4 2022 to a low of -$1.1 million in Q3 2025.
- Historically, Common Equity has averaged -$736008.6 across 5 years, with a median of -$705843.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Common Equity sank 642.21% in 2022, then grew 11.74% in 2025.
- A 5-year view of Common Equity shows it stood at -$544830.0 in 2022, then retreated by 21.36% to -$661232.0 in 2023, then declined by 27.08% to -$840273.0 in 2024, then rose by 11.74% to -$741649.0 in 2025, then retreated by 4.5% to -$775025.0 in 2026.
- The last three Common Equity figures came in at -$775025.0 (Q1 2026), -$741649.0 (Q4 2025), and -$1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Greater Cannabis Company | - | - | - | -775,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -775,025.00 |
| Dec 31, 2025 | -741,649.00 |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Mar 31, 2025 | -823,984.00 |
| Dec 31, 2024 | -840,273.00 |
| Sep 30, 2024 | -796,925.00 |
| Jun 30, 2024 | -750,760.00 |
| Mar 31, 2024 | -705,843.00 |
| Dec 31, 2023 | -661,232.00 |
| Sep 30, 2023 | -650,371.00 |
| Jun 30, 2023 | -632,941.00 |
| Mar 31, 2023 | -587,898.00 |
| Dec 31, 2022 | -544,830.00 |
| Sep 30, 2022 | -561,429.00 |
| Jun 30, 2022 | -641,653.00 |
| Mar 31, 2022 | -616,748.00 |
| Dec 31, 2021 | -469,062.00 |
| Sep 30, 2021 | -272,731.00 |
| Jun 30, 2021 | -86,452.00 |